Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Charilaos Filippakis, Ph.D.

Concepts

This page shows the publications Charilaos Filippakis has written about Humans.
Connection Strength

0.028
  1. Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R. Oncotarget. 2017 Jun 13; 8(24):38099-38112.
    View in: PubMed
    Score: 0.008
  2. The enhanced host-cell permissiveness of human cytomegalovirus is mediated by the Ras signaling pathway. Biochim Biophys Acta. 2011 Oct; 1813(10):1872-82.
    View in: PubMed
    Score: 0.006
  3. Herpesviruses: hijacking the Ras signaling pathway. Biochim Biophys Acta. 2010 Jul; 1803(7):777-85.
    View in: PubMed
    Score: 0.005
  4. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Proc Natl Acad Sci U S A. 2018 07 03; 115(27):E6274-E6282.
    View in: PubMed
    Score: 0.002
  5. Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol. 2015 Jul; 53(1):33-41.
    View in: PubMed
    Score: 0.002
  6. Autophagy : Moving Benchside Promises to Patient Bedsides. Curr Cancer Drug Targets. 2015; 15(8):684-702.
    View in: PubMed
    Score: 0.002
  7. Replication stress and mitotic dysfunction in cells expressing simian virus 40 large T antigen. J Virol. 2013 Dec; 87(24):13179-92.
    View in: PubMed
    Score: 0.002
  8. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency. Eur J Med Chem. 2011 Jun; 46(6):2586-95.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.